Canada markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.29-0.63 (-2.34%)
At close: 04:00PM EDT
25.80 -0.49 (-1.86%)
After hours: 06:15PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.22B
Enterprise Value 2.94B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.08
Price/Book (mrq)4.48
Enterprise Value/Revenue 4.70
Enterprise Value/EBITDA -13.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.89
52-Week Change 3-50.79%
S&P500 52-Week Change 323.57%
52 Week High 363.57
52 Week Low 324.60
50-Day Moving Average 336.72
200-Day Moving Average 344.32

Share Statistics

Avg Vol (3 month) 31.56M
Avg Vol (10 day) 32.36M
Shares Outstanding 5105.65M
Implied Shares Outstanding 6119.71M
Float 8103.81M
% Held by Insiders 12.37%
% Held by Institutions 194.76%
Shares Short (Apr 15, 2024) 48.87M
Short Ratio (Apr 15, 2024) 47
Short % of Float (Apr 15, 2024) 410.58%
Short % of Shares Outstanding (Apr 15, 2024) 47.44%
Shares Short (prior month Mar 15, 2024) 48.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -42.26%
Operating Margin (ttm)-42.12%

Management Effectiveness

Return on Assets (ttm)-13.06%
Return on Equity (ttm)-34.75%

Income Statement

Revenue (ttm)625.45M
Revenue Per Share (ttm)5.30
Quarterly Revenue Growth (yoy)5.00%
Gross Profit (ttm)N/A
EBITDA -164.14M
Net Income Avi to Common (ttm)-264.3M
Diluted EPS (ttm)-2.24
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)371.81M
Total Cash Per Share (mrq)3.11
Total Debt (mrq)92.18M
Total Debt/Equity (mrq)12.82%
Current Ratio (mrq)5.22
Book Value Per Share (mrq)6.01

Cash Flow Statement

Operating Cash Flow (ttm)-26.8M
Levered Free Cash Flow (ttm)16.96M